Issue Date: February 14, 2011
Nitto Denko Acquires Avecia Biotechnology
Japan’s Nitto Denko has acquired Avecia Biotechnology, a maker of oligonucleotides for drug industry customers. Based in Milford, Mass., Avecia Biotechnology claims to be the market leader in contract manufacturing and related services for nucleic acid drugs. Nitto Denko says its subsidiary in Oceanside, Calif., offers solid polymer support technology for nucleic acid drug production. Avecia Biotechnology was the last piece of England’s Avecia, once a leading fine and specialty chemicals . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society